Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative testing and genetic analysis solutions, announced today its wholly owned subsidiary, Sequenom Laboratories, has signed a national agreement with a leading benefits ...
Ariosa Diagnostics, maker of the Harmony prenatal test, has announced the publication of two clinical studies involving twin pregnancies in Fetal Diagnosis and Therapy. The two studies provide information on how to consider use of ...
Tags: Ariosa Diagnostics, prenatal test
Natera, a genetic testing company, has announced that DiagCor, a manufacturer of in-vitro diagnostic products and service provider of clinical diagnostic tests, has signed an agreement to launch Natera’s Panorama non-invasive prenatal ...
Tags: Prenatal Test, Natera
Verinata Health has introduced a non-invasive prenatal test to detect autosomal and fetal sex chromosome aneuploidies for high-risk pregnancies. The expanded indication of verifi prenatal blood test detects Turner syndrome(Monosomy ...
Tags: Verinata Health, non-invasive prenatal test, high-risk pregnancies
Ariosa Diagnostics has announced the availability of Harmony prenatal test in the US and Canada through Laboratory Corporation of America Holdings (LabCorp) and Integrated Genetics. The non-invasive test uses a directed approach to ...
Tags: Integrated Genetics, non-invasive test, Harmony prenatal test
Ariosa Diagnostics will present its non-invasive prenatal test's clinical data at the American Society of Human Genetics (ASHG) Annual Meeting being held in San Francisco, California, US, from 6 - 11 November 2012. The non-invasive test, ...
Tags: non-invasive prenatal test, ASHG, analysis, cell-free DNA
The US District Court for the Northern District of California has denied the preliminary injunction motion filed by Sequenom against Ariosa Diagnostics. In the preliminary injunction case, Sequenom said it sought to enjoin Ariosa ...
Tags: Harmony Prenatal Test, cell-free DNA, the preliminary injunction case